MedPath

NOVO-ETODOLAC 300 MG

NOVO-ETODOLAC 300 MG

Discontinued
DIN Number

02242206

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242206
AIG Number0116345002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AB08 ETODOLAC
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ETODOLACActive
Strength: 300 MG / CAP
Monograph: ETODOLAC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.